4//SEC Filing
Boylan James P 4
Accession 0001104659-24-100332
CIK 0001953926other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:55 PM ET
Size
6.0 KB
Accession
0001104659-24-100332
Insider Transaction Report
Form 4
Boylan James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-12+37,000→ 37,000 totalExercise: $17.00Exp: 2034-09-11→ Common Stock (37,000 underlying)
Footnotes (2)
- [F1]Mr. Boylan has agreed to receive and hold for the benefit of, Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.
- [F2]The option vests in equal annual installments over three years beginning on September 12, 2025, the first anniversary of the vesting commencement date, subject to continued service.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001953094
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:55 PM ET
- Size
- 6.0 KB